Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using...

No prior work had resolved which contrast agent best quantifies vessel growth within engineered bladder tissues. Standard small molecules often leak rapidly from vessels, complicating physiological measurements in regenerative grafts. This uncertainty drove researchers to investigate macromolecular alternatives for improved imaging precision. Prior research has shown that vascular endothelial growth factor promotes vessel formation in various biological scaffolds. However, current imaging protocols lack standardized methods for evaluating these complex tissue constructs. That limitation prevents clinicians from accurately monitoring graft integration after surgical implantation. Researchers now seek reliable biomarkers to assess the functional status of newly formed microvasculature. This investigation addresses the need for refined diagnostic tools in tissue engineering applications.

The study aims to compare Gadomer and gadolinium diethylenetriamine pentaacetic acid for quantifying angiogenesis in engineered bladder constructs. Researchers sought to determine which contrast agent provides more accurate physiological measurements of blood vessel development. This investigation addresses the challenge of monitoring graft integration in regenerative medicine applications. The team focused on constructs enhanced with varying levels of vascular endothelial growth factor to induce different degrees of vessel formation. By evaluating these agents, the authors intended to establish a more precise imaging protocol for future tissue engineering research. The motivation stems from the need to distinguish functional microvasculature from non-functional or leaky vessels in implanted tissues. No prior work had systematically compared these specific agents for this purpose in bladder models. This effort provides a foundation for improved diagnostic imaging in complex tissue-engineered grafts.

The team performed dynamic contrast-enhanced magnetic resonance imaging on twelve rabbits implanted with vascular endothelial growth factor-enhanced bladder constructs. Investigators administered both Gadomer and gadolinium diethylenetriamine pentaacetic acid sequentially to each animal model. A one-hour waiting period separated the two imaging procedures to prevent signal overlap. Scientists calculated pharmacokinetic parameters including plasma volume fraction and the transfer constant from the resulting image data. Model-free analysis involved determining the area under the concentration-time curve for each agent. Histological examination of microvessel density provided a gold standard for validating the imaging findings. Evans blue dye permeability assays assessed the functional integrity of the newly formed vessels. Statistical comparisons identified significant differences between the two contrast media regarding their sensitivity to vascular growth.

The strongest finding indicates that Gadomer provides better resolution of microvessel function than gadolinium diethylenetriamine pentaacetic acid. Plasma volume fraction calculated with Gadomer successfully distinguished vascular density differences with high statistical significance. Specifically, Gadomer-derived plasma volume fraction achieved a p-value below 0.005, whereas other metrics were less sensitive. Both the plasma volume fraction and the area under the concentration-time curve showed strong correlations with histological microvessel density. In contrast, gadolinium diethylenetriamine pentaacetic acid only distinguished density differences through the area under the concentration-time curve. Researchers observed that microvessel density was significantly elevated at the highest vascular endothelial growth factor concentration. However, no significant changes occurred in the transfer constant across the different experimental groups. The study confirms that macromolecular agents are superior for monitoring angiogenesis in these specific tissue grafts.

The authors propose that macromolecular agents offer superior utility for tracking vessel development in bladder grafts. Gadomer provides more accurate and precise quantification of microvessel function than standard small-molecule alternatives. Pharmacokinetic modeling benefits significantly from the use of larger contrast agents in these specific tissue environments. The study suggests that plasma volume fraction serves as a robust metric for distinguishing vascular density. Both the plasma volume fraction and the area under the concentration-time curve correlate well with histological vessel counts. Gd-DTPA remains less effective at resolving differences in microvessel density compared to its macromolecular counterpart. These findings highlight the importance of agent selection when designing longitudinal imaging studies for regenerative medicine. Future monitoring of engineered tissues should prioritize agents that minimize leakage to ensure physiological accuracy.